HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain

Molecular Therapy

Volumn 8, Issue 3, 2003, Pages 367-375

  Hao, Shuanglin ^a   Mata, Marina ^a   Wolfe, Darren ^b   Huang, Shaohua ^b   Glorioso, Joseph C ^b   Fink, David J ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

GDNF; Gene therapy; HSV; Pain

Indexed keywords

COMPLEMENTARY DNA; GLIAL CELL DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; PROTEIN C FOS; UNCLASSIFIED DRUG; VIRUS VECTOR;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS; MEDICAL CARE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD DORSAL HORN; SPINAL GANGLION; SPINAL NERVE; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

ANIMALIA; SIMPLEXVIRUS;

EID: 0141521638     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00185-0     Document Type: Article

References (59)

1. Pirart, J. (1978). Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1: 168-188.
2. Pirart, J. (1978). Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1: 252-263.
3. Collins, S. L., Moore, R. A., McQuay, H. J., and Wiffen, P. (2000). Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review. J. Pain Symptom Manage. 20: 449-458.
4. Bennett, G. J., and Xie, Y. K. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.
5. Seltzer, Z., Dubner, R., and Shir, Y. (1990). A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury, Pain 43: 205-218.
6. Kim, S. H., and Chung, J. M. (1992). An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50: 355-363.
7. Bennett, G. J. (1999). Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies? Proc. Natl. Acad. Sci. USA 96: 7737-7738.
8. Gold, M. S. (2000). Spinal nerve ligation: What to blame for the pain and why. Pain 84: 117-120.
9. Yaksh, T. L. (1999). Spinal systems and pain processing: Development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol. Sci. 20: 329-337.
10. Airaksinen, M. S., and Saarma, M. (2002). The GDNF family: Signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3: 383-394.
11. Lin, L. F. H., Doherty, D. H., Lile, J. D., Bektesh, S., and Collins, F. (1993). GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
12. Molliver, D. C., et al. (1997). IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron 19: 849-861.
13. Zwick, M., et al. (2002). Glial cell line-derived neurotrophic factor is a survival factor for isolectin B4-positive, but not vanilloid receptor 1-positive, neurons in the mouse. J. Neurosci. 22: 4057-4065.
14. Bennett, D. L., et al. (1998). A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J. Neurosci. 18: 3059-3072.
15. Nosrat, C. A., Tomac, A., Hoffer, B. I., and Olson, L. (1997). Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs. Exp. Brain Res. 115: 410-422.
16. Araujo, D. M., Hilt, D. C., Miller, P. J., Wen, D., Jiao, S., and Lapchak, P. A. (1997). Ret receptor tyrosine kinase immunoreactivity is altered in glial cell line-derived neurotrophic factor-responsive neurons following lesions of the nigrostriatal and septohippocampal pathways. Neuroscience 80: 9-16.
17. Boucher, T. J., Okuse, K., Bennett, D. L., Munson, J. B., Wood, J. N., and McMahon, S. B. (2000). Potent analgesic effects of GDNF in neuropathic pain states. Science 290: 124-127.
18. Nutt, J. G., et al. (2003). Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 60: 69-73.
19. Apfel, S. C. (2002). Is the therapeutic application of neurotrophic factors dead? Ann. Neurol. 51: 8-11.
20. Mata, M., Glorioso, J. C., and Fink, D. J. (2002). Targeted gene delivery to the nervous system using herpes simplex virus vectors. Physiol. Behav. 77: 483-488.
21. Krisky, D. M., et al. (1998). Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther. 5: 1517-1530.
22. Ozuer, A., Wechuck, J. B., Goins, W. F., Wolfe, D., Glorioso, J. C., and Ataai, M. M. (2002). Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors. Biotechnol. Bioeng. 77: 685-692.
23. Chattopadhyay, M., et al. (2002). In vivo gene therapy of pyridoxine-induced neuropathy by HSV-mediated gene transfer of neurotrophin-3. Ann. Neurol. 51: 19-27.
24. Chattopadhyay, M., Goins, W., Glorioso, J. C., Mata, M., and Fink, D. J. (2002). HSV-mediated gene transfer of NGF in cisplatin neuropathy. Mol. Ther. 5: 5244.
25. Goss, J. R., Goins, W. F., Lacomis, D., Mata, M., Glorioso, J. C., and Fink, D. J. (2002). Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes 51: 2227-2232.
26. Chattopadhyay, M., et al. (2003). Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals. Eur. J. Neurosci. 17: 732-740.
27. Hao, S., Mata, M., Goins, W., Glorioso, J. C., and Fink, D. J. (2003). Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect. Pain 102: 135-142.
28. Goss, J. R., et al. (2002). Herpes vector-mediated expression of proenkephalin reduces pain-related behavior in a model of bone cancer pain. Ann. Neurol. 52: 662-665.
29. Malan, T. P., Mata, H. P., and Porreca, F. (2002). Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain. Anesthesiology 96: 1161-1167.
30. Ramakrishnan, R., Levine, M., and Fink, D. J. (1994). PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J. Virol. 68: 7083-7091.
31. Hunt, S. P., Pini, A., and Evan, G. (1987). Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328: 632-634.
32. Catheline, G., Le Guen, S., and Besson, J. M. (2001). Intravenous morphine does not modify dorsal horn touch-evoked allodynia in the mononeuropathic rat: A Fos study. Pain 92: 389-398.
33. Black, J. A., et al. (1999). Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons. J. Neurophysiol. 82: 2776-2785.
34. Fjell, J., Cummins, T. R., Fried, K., Black, J. A., and Waxman, S. G. (1999). In vivo NGF deprivation reduces SNS expression and TTX-R sodium currents in 1154-negative DRG neurons. J. Neurophysiol. 81: 803-810.
35. Brock, J. A., McLachlan, E. M., and Belmonte, C. (1998). Tetrodotoxin-resistant impulses in single nociceptor nerve terminals in guinea-pig cornea. J. Physiol 512(Pt. 1): 211-217.
36. Quasthoff, S., Grosskreutz, J., Schroder, J. M., Schneider, U., and Grafe, P. (1995). Calcium potentials and tetrodotoxin-resistant sodium potentials in unmyelinated C fibres of biopsied human sural nerve. Neuroscience 69: 955-965.
37. Decosterd, I., Ji, R. R., Abdi, S., Tate, S., and Woolf, C. J. (2002). The pattern of expression of the voltage-gated sodium channels Na(v)1.8 and Na(v)1.9 does not change in uninjured primary sensory neurons in experimental neuropathic pain models. Pain 96: 269-277.
38. Woolf, C. J., Shortland, P., and Coggeshall, R. E. (1992). Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 355: 75-78.
39. Woolf, C. J., Shortland, P., Reynolds, M., Ridings, J., Doubell, T., and Coggeshall, R. E. (1995). Reorganization of central terminals of myelinated primary afferents in the rat dorsal horn following peripheral axotomy. J. Comp. Neurol. 360: 121-134.
40. Mannion, R. J., Doubell, T. P., Coggeshall, R. E., and Woolf, C. J. (1996). Collateral sprouting of uninjured primary afferent A-fibers into the superficial dorsal horn of the adult rat spinal cord after topical capsaicin treatment to the sciatic nerve. J. Neurosci. 16: 5189-5195.
41. Wu, G., et al. (2001 ). Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J. Neurosci. 21: RC140.
42. Eaton, M. J. (2000). Emerging cell and molecular strategies for the study and treatment of painful peripheral neuropathies. J. Peripher. Nerv. Syst. 5: 59-74.
43. Mata, M., Zhang, M., Hu, X., and Fink, D. J. (2001). HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system. J. Neurovirol. 7: 476-480.
44. Tomishima, M. J., Smith, G. A., and Enquist, L. W. (2001). Sorting and transport of alpha herpesviruses in axons. Traffic 2: 429-436.
45. Wilson, S. P., Yeomans, D. C., Bender, M. A., Lu, Y., Goins, W. F., and Glorioso, J. C. (1999). Anti hyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc. Natl. Acad. Sci. USA 96: 3211-3216.
46. Braz, J., et al. (2001 ). Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J. Neurosci. 21: 7881-7888.
47. Goss, J. R., Mata, M., Goins, W. F., Wu, H. H., Glorioso, J. C., and Fink, D. J. (2001). Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther. 8: 551-556.
48. Dragunow, M., Currie, R. W., Robertson, H. A., and Faull, R. L. (1989). Heat shock induces c-fos protein-like immunoreactivity in glial cells in adult rat brain. Neurology 106: 105-109.
49. Hammond, D. L., Wang, H., Nakashima, N., and Basbaum, A. I. (1998). Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat. J. Pharmacol. Exp. Ther. 284: 378-387.
50. Molander, C., Hongpaisan, J., and Grant, G. (1992). Changing pattern of c-FOS expression in spinal cord neurons after electrical stimulation of the chronically injured sciatic nerve in the rat. Neuroscience 50: 223-236.
51. Shortland, P., and Molander, C. (1998). The time-course of abeta-evoked c-fos expression in neurons of the dorsal horn and gracile nucleus after peripheral nerve injury. Brain Res. 810: 288-293.
52. Krisky, D. M., Marconi, P. C., Oligino, T., Rouse, R. J., Fink, D. J., and Glorioso, J. C. (1997). Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther. 4: 1120-1125.
53. Gibson, U. E., Heid, C. A., and Williams, P. M. (1996). A novel method for real time quantitative RT-PCR. Genome Res. 6: 995-1001.
54. Ghassemi, F., Dib-Hajj, S. D., and Waxman, S. G. (2001). Beta 1 adducin gene expression in DRG is developmentally regulated and is upregulated by glial-derived neurotrophic factor and nerve growth factor. Brain Res. Mol. Brain Res. 90: 118-124.
55. Yamagata, K., Tagami, M., Ikeda, K., Tsumagari, S., Yamori, Y., and Nara, Y. (2002). Differential regulation of glial cell line-derived neurotrophic factor (GDNF) mRNA expression during hypoxia and reoxygenation in astrocytes isolated from stroke-prone spontaneously hypertensive rats. Glia 37: 1-7.
56. Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., and Yaksh, T. L. (1994). Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53: 55-63.
57. Dixon, W. J. (1980). Efficient analysis of experimental observations. Annu. Rev. Pharmacol. Toxicol. 20: 441-462.
58. Ma, Q. P., and Woolf, C. J. (1996). Basal and touch-evoked fos-like immunoreactivity during experimental inflammation in the rat. Pain 67: 307-316.
59. Hao, S., Takahata, O., Mamiya, K., and Iwasaki, H. (2002). Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems. Life Sci. 71: 571-580.